Asensus Announces Kitakyushu General Hospital in Japan to Initiate Second Senhance System
03 Janvier 2023 - 12:55PM
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device
company that is digitizing the interface between the surgeon and
the patient to pioneer a new era of Performance-Guided Surgery™,
today announced that Kitakyushu General Hospital (“Kitakyushu”), a
hospital in the Kyushu area of Japan, entered into an agreement to
lease and utilize a second Senhance® Surgical System, at the end of
December 2022. Kitakyushu is the first hospital to install multiple
Senhance Surgical Systems.
The hospital previously initiated their first Senhance system in
January of 2020, and since has completed over 300 procedures
utilizing Performance-Guided Surgery.
“We are very excited to see one of our first Japanese placements
expanding their Senhance program to include a second system,” said
Anthony Fernando, Asensus Surgical President and CEO. “This
milestone speaks to the clinical value that the Senhance System and
the Intelligent Surgical Unit™ bring to a surgeon, and hospital, as
well as the wide applicability of the system to many different
types of procedures in multiple specialities.”
Asensus Surgical's technology platform, the Senhance Surgical
System, is the first of its kind digital laparoscopic platform that
leverages augmented intelligence to provide unmatched performance
and patient outcomes through machine learning. Senhance goes beyond
the typical surgical robotic systems, providing surgical assurance
through haptic feedback, eye-tracking camera control, and 3D
visualization, and is the first platform to offer 3mm instruments
(the smallest instrument available in the world on a robotic
surgical platform). The Senhance Surgical System is powered by the
Intelligent Surgical Unit™ (ISU™). The ISU enables machine
vision-driven control of the camera for a surgeon by responding to
commands and recognizing certain objects and locations in the
surgical field, and allows a surgeon to change the visualized field
of view using the movement of their instruments.
“Given the immense success of the first Senhance System, we are
thrilled to be adding another unit to our surgical offerings,” said
Dr. Naoki Nagata, President of Kitakyushu General Hospital. “We
have received very positive feedback from our Senhance surgeons and
patients in the last 3 years, and are pleased to be expanding the
utilization of the Senhance Systems to deliver better and safer
outcomes for our patients.”
About Kitakyushu General Hospital
Kitakyushu General Hospital is a prestigious institution and is
recognized as one of the major hospitals in Kitakyushu. It offers
both advanced and emergency medical care and is a core part of the
Kitakyushu Hospital Group. It is a 360-bed facility that contains a
critical care center and is the only general hospital in the
Kitakyushu Hospital Group.
About Asensus Surgical, Inc.
Asensus Surgical, Inc. is digitizing the interface between the
surgeon and patient to pioneer a new era of Performance-Guided
Surgery by unlocking clinical intelligence for surgeons to enable
consistently superior outcomes and a new standard of surgery. This
builds upon the foundation of Digital Laparoscopy with the Senhance
Surgical System powered by the Intelligent Surgical Unit (ISU) to
increase surgeon control and reduce surgical variability. With the
addition of machine vision, augmented intelligence, and deep
learning capabilities throughout the surgical experience, we intend
to holistically address the current clinical, cognitive and
economic shortcomings that drive surgical outcomes and value-based
healthcare. Learn more about Performance-Guided Surgery and Digital
Laparoscopy with the Senhance Surgical System here:
www.senhance.com. Now available for sale in the
US, EU, Japan, Russia, and select other countries. For a complete
list of indications for use, visit:
www.senhance.com/indications. For more
information, visit www.asensus.com.
Follow Asensus
Email Alerts: https://ir.asensus.com/email-alerts
LinkedIn:
https://www.linkedin.com/company/asensus-surgical-inc
Twitter: https://twitter.com/AsensusSurgical
YouTube: https://www.youtube.com/c/transenterix
Vimeo: https://vimeo.com/asxc
TikTok: https://www.tiktok.com/@asensus_surgical
Forward-Looking Statements
This press release includes statements relating to the Senhance
Surgical System and Kitakyushu General Hospital initiating its
second Senhance Surgical System. These statements and other
statements regarding our future plans and goals constitute "forward
looking statements" within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934, and are intended to qualify for the safe harbor from
liability established by the Private Securities Litigation Reform
Act of 1995. Such statements are subject to risks and uncertainties
that are often difficult to predict, are beyond our control and
which may cause results to differ materially from expectations and
include whether the second Senhance Surgical System at Kitakyushu
General Hospital speaks to the clinical value that the Senhance
System and the ISU bring to a surgeon and hospital and whether
expanding the utilization of Senhance Systems by Kitakyushu General
Hospital will deliver better and safer outcomes for its patients.
For a discussion of the risks and uncertainties associated with the
Company’s business, please review our filings with the Securities
and Exchange Commission (SEC), including our Annual Report on Form
10-K for the year ended December 31, 2021, filed with the SEC on
February 28, 2022 and our other filings we make with the SEC. You
are cautioned not to place undue reliance on these forward-looking
statements, which are based on our expectations as of the date of
this press release and speak only as of the origination date of
this press release. We undertake no obligation to publicly update
or revise any forward-looking statement, whether as a result of new
information, future events or otherwise.
INVESTOR CONTACT:
Mark Klausner or Mike Vallie, 443-213-0499invest@asensus.com
MEDIA CONTACT:
Isabella Rodriguez, 708-833-1572CG Lifeirodriguez@cglife.com
Asensus Surgical (AMEX:ASXC)
Graphique Historique de l'Action
De Nov 2023 à Déc 2023
Asensus Surgical (AMEX:ASXC)
Graphique Historique de l'Action
De Déc 2022 à Déc 2023